BioMed Central Lin HT et al
NABP.pharmacy Pharmacy Times
Stahl quote: "Follow the FDA label and never get anybody better" [22:10] When GLP-1s aren't appropriate [24:01] Case study: patient on paliperidone gaining weight despite tirzepatide [25:52] Discovery of nucleus tractus solitaris [28:26] The "are we allowed to prescribe this?" debate [29:10] Valproic acid, propranolol, and scope of practice [30:01] Bipolar disorder, obesity, and mood episode frequency [30:49] Moving beyond the monoamine hypothesis [31:19] UK paper: no proof depression is serotonin deficiency [33:23] Alternative treatments: TMS, ketamine, GLP-1s [34:03] Dr
Improves Athletic Performance ALCAR can increase energy situations, thereby enhancing athletic performance
Slowing down gastric emptying, thus promoting a feeling of fullness and reducing appetite
These results reflect the benefit of combining medication with a structured behaviour-change programme